GET DAILY SIGNALSDocebo (DCBO) Posts Q3 Revenue Growth of +14% and Lifts Full-Year Outlook
Key Takeaways
- Docebo reported third quarter fiscal 2026 total revenue of $70.33 million, up roughly 14% from $61.62 million a year earlier.
- Adjusted diluted earnings per share (EPS) came in at $0.55, exceeding the consensus estimate of $0.53.
- Annual Recurring Revenue (ARR) — the company's key measure of recurring subscription value — rose 11% year over year to $261.5 million.
- Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 34% to $16.65 million.
- Management raised its full-year 2026 revenue growth outlook to approximately 14%, up from an initial 10.6% midpoint guided in February.
- The company announced a one-time special dividend of approximately $60 million.
- For more detail on Docebo's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages available on Tickeron.
- Discover actionable trading ideas powered by automation by exploring Trending AI Robots.
Why These Results Matter
Docebo sits at the intersection of corporate learning and artificial intelligence, positioning its platform for organizations that want to move past basic compliance training into skills intelligence and AI-driven knowledge tools. The Q3 2026 report gave investors a clear look at whether that approach is driving faster subscription growth, larger contracts, and better profitability. With the stock up roughly 37% in 2026 through early November, the quarter also tested whether those elevated expectations still held up.
Breaking Down the Numbers
Docebo reported third quarter fiscal 2026 revenue of $70.33 million, up 14.1% from $61.62 million in the same period a year ago and slightly above consensus. Adjusted diluted EPS reached $0.55, ahead of the $0.53 estimate and up 61.8% from $0.34 a year earlier. That marked the fourth straight quarter of positive earnings surprises.
Operating metrics showed continued momentum. Annual Recurring Revenue (ARR) grew 11% to $261.5 million, while Average Contract Value (ACV) rose 24% to $77,900, pointing to larger enterprise deals. Adjusted EBITDA increased 34.3% to $16.65 million, and free cash flow came in at $6.11 million. Management raised full-year 2026 revenue growth guidance to about 14% and announced a roughly $60 million one-time special dividend, underscoring confidence in the recurring cash flow model. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Reaction and Sentiment
Sentiment ahead of the report was already positive, given DCBO's strong 2026 performance and improving growth path. The earnings beat, raised outlook, and special dividend added to the bullish case for a business showing both accelerating subscription revenue and disciplined margin expansion. Investors viewed the dividend as a sign of management’s confidence in sustainable recurring cash flows. On the call, attention centered on early traction for the new “Knowledge” product, progress in the government vertical, and the balance between reinvestment and returning capital to shareholders.
What to Watch Going Forward
Investors will want to see whether Docebo can keep subscription revenue accelerating sequentially. Management guided to roughly 12.8% subscription growth in the fourth quarter, up from 12.4% in Q3, and now sees full-year 2026 revenue growth near 14% — a notable increase from the 10.6% midpoint guided nine months earlier.
Product adoption remains key. The company reported about 600 beta customers for its new “Knowledge” offering, which moves Docebo into enterprise knowledge management powered by AI. How quickly those users convert to paid expansion will influence the 2027 growth story.
Margin and capital allocation trends also deserve attention. Management expects to hold 20%-plus EBITDA margins while investing in healthcare and government sales capacity. The special dividend, partly funded by increased debt, leaves the company in a net debt position that investors will track alongside buybacks and any future acquisitions.
Refining Research with AI Tools
When I want a structured way to compare names like DCBO against peers or spot shifting conditions quickly, Tickeron’s AI Screener has become a regular part of my process. It lets me filter on technical patterns, fundamentals, and AI signals without spending hours on manual work, which helps me stay focused on the broader picture rather than getting lost in the details.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
DCBO's RSI Oscillator recovers from overbought zone
The 10-day RSI Oscillator for DCBO moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In 19 of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 53 cases where DCBO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DCBO as a result. In 60 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The Moving Average Convergence Divergence Histogram (MACD) for DCBO turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCBO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
DCBO broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The 10-day moving average for DCBO crossed bullishly above the 50-day moving average on October 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +4.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where DCBO advanced for three days, in 203 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 109 of 162 cases where DCBO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DCBO's P/B Ratio (-2361.869) is very low in comparison to the industry average of (-1.942). P/E Ratio (24.551) is within average values for comparable stocks, (15.235). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (2.558) is also within normal values, averaging (70.854).
The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. DCBO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DCBO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement